NCT01242202View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

October 21, 2010

Primary Completion Date

May 25, 2012

Study Completion Date

May 25, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

alpha glucosidase inhibitor

oral

Trial Locations (6)

Unknown

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY